Key result
In vitro overexpression of ACE2 in A549 non-small cell lung cancer cells increased the proportion of cells in the G0/G1 phase and inhibited VEGFa production.
Why the study?
Does ACE2 overexpression inhibit cell growth and VEGFa production in non-small cell lung cancer cells?
Does ACE2 overexpression inhibit cell growth and VEGFa production in non-small cell lung cancer cells?
Answers are grounded in this paper and cite their sources.
ACE2 expression is decreased in NSCLC, and its overexpression may have a protective effect by inhibiting tumor cell growth and angiogenesis.
Angiotensin II (AngII) is a multifunctional bioactive peptide and previous studies have shown that the renin-angiotensin system (RAS) of both host and tumor are important in tumor growth and angiogenesis in lung cancer. Angiotensin-converting enzyme 2 (ACE2) is a newly identified component of RAS, with 42% amino acid homology to ACE. However, the expression and function of ACE2 in non-small cell lung cancer (NSCLC) are still unclear. In the present study, we analyzed ACE2 expression in NSCLC tissue by Western blot analysis and immunohistochemistry. AngII concentrations in the tissue homogenate were also detected using radio-immunoassay. We also examined the function of ACE2 by transducing A549 cells with MSCV-ACE2. We have shown for the first time that ACE2 expression decreased in NSCLC tissue in which AngII was higher than the matching non-malignant tissues. A concentration of 10(-6) mol/l of AngII significantly increased expression of vascular endothelial growth factor a (VEGFa) and AT1-R and decreased ACE2 expression. We also found that overexpression of ACE2 may have a protective effect by inhibiting cell growth and VEGFa production in vitro. ACE2 may become a target of novel strategies to treat NSCLC.
No takes yet. Share an insight, caveat, or question.
Wan Wan (2010) studied Non-small cell lung cancer (n=83). ACE2 overexpression vs. Vector control was evaluated on Proportion of A549 cells in G0/G1 phase (p=<0.01). In vitro overexpression of ACE2 in A549 non-small cell lung cancer cells increased the proportion of cells in the G0/G1 phase and inhibited VEGFa production.
Synapse has enriched 10 related papers. Consider them for comparative context: